Navigation Links
Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
Date:11/10/2008

3100 has been generally well tolerated, with

no reports of serious adverse events deemed related to the drug.

-- Approximately 120 patients have been enrolled in the trial with

enrollment completed at doses up to 360 mg/day. A total of 73 patients

in the three lowest expanded dose groups (60, 150, and 240 mg/day) have

been followed for more than 24 weeks. Of these 73 patients, 31

patients (42 percent) have received MDV3100 for greater than 24 weeks.

Dose escalation in the trial is continuing; the 360 mg/day expansion

group is completely enrolled, dose escalation is in progress at 480

mg/day, and initial dosing at 600 mg/day has started. Thus far a

maximum tolerated dose (MTD) has not been reached.

-- Medivation expects to seek FDA agreement to begin a pivotal Phase 3

registration study in castration-resistant prostate cancer patients in

2009.

Third Quarter 2008 Financial Results

Medivation reported a net loss for the quarter ended September 30, 2008 of $20.5 million, or $0.68 per share, compared with a net loss of $9.4 million, or $0.34 per share, for the same period in 2007. For the nine months ended September 30, 2008, the net loss was $54.5 million, or $1.86 per share, compared with a net loss of $22.2 million, or $0.80 per share, for the same period in 2007.

Total operating expenses for the nine months ended September 30, 2008 were $20.6 million, compared with $9.8 million for the same period in 2007. The increase in operating expenses for the third quarter of 2008 compared with the same period in 2007 is primarily due to increased development costs associated with Dimebon and MDV3100.

For the nine months ended September 30, 2008, total operating expenses were $55.3 million, compared with total operating expenses of $23.7 million for the same period in 2007. These figures include non-cash stock-based compensation expense
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Medivation Announces Third Quarter 2008 Teleconference and Webcast on November 10, 2008
2. Medivation Announces Expiration of Hart-Scott-Rodino Waiting Period for Collaboration With Pfizer
3. Medivation Announces Presentation of 24-Week Clinical Data of MDV3100 in Castration-Resistant Prostate Cancer Patients
4. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
5. Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
6. Medivation Announces Participation in Upcoming Conferences
7. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
8. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
9. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
10. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
11. Medivation Announces Senior Management Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... New York (PRWEB) August 29, 2014 ... valued at $5.6 billion in 2019. It is ... from 2013 to 2019, and was valued at ... report published by Transparency Market Research. , For ... visit: http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research report, ...
(Date:8/29/2014)... August 29, 2014 Pittcon is pleased ... and colleague Koichiro Matsuda, Horiba Scientific, have organized a ... 5, 2014. JASIS , Asia’s largest analytical and ... in Makuhari Messe, Japan. , The four speakers ... Bioanalysis from Single Molecules to Single Cells” will present ...
(Date:8/29/2014)... Hills, NY (PRWEB) August 29, 2014 ... Burnt Hills Veterinary Hospital are seeking candidates to participate ... dogs with osteoarthritis. The ultimate goal of this ... donor stem cells into one or two arthritically affected ... treated joints. , Candidates for the current investigational ...
(Date:8/29/2014)... 29, 2014 Due to a misstatement posted ... the Adult Stem Cell Technology Center, LLC ( ASCTC ) ... cell therapy research that might benefit ALS patients. Because ... new stem cell technologies and therapeutic applications, FRC listed ASCTC ... Challenge donors who wish not to support research that ...
Breaking Biology Technology:Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3
... - Mikael Dohlsten, M.D., Ph.D., To Succeed As President, ... Wyeth (NYSE: WYE ),today announced that Robert R. ... and Senior Vice President, Wyeth, later this,year. He will ... Ruffolo joined Wyeth in November 2000 and has been ...
... Intense global competition,and today,s networked economy have been ... the strategy of the next century. A,strategic alliance ... be sustainable and,mutually beneficial., How to build ... Forging,Partnerships That Work is a roadmap to successful ...
... /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT),a vaccine development ... vaccine delivery system used to increase the efficacy ... to protect the,DepoVax(TM) concept., "The results from ... with a single dose," remarked Marc Mansour, vice,president ...
Cached Biology Technology:Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement 2Biopharmaceutical Alliances: Forging Partnerships That Work 2ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform 2
(Date:8/28/2014)... for delivering compounds that could positively impact ... may be possible, thanks to researchers in ... semi-soft vaginal suppository made from the seaweed-derived ... antiviral drug Tenofovir provides a woman-initiated, drug-delivery ... of sexually transmitted infections during unprotected heterosexual ...
(Date:8/28/2014)... will be built worldwide by 2050. Many of these ... bring an influx of destructive loggers, hunters and illegal ... a ,global roadmap, for prioritising road building across the ... development and environmental protection. , The map has two ... of ecosystems and a ,road-benefits, layer that estimates the ...
(Date:8/28/2014)... needed to ensure safeguards are in place to protect ... ONE , researchers from Monash University, Stellenbosch University and ... from different studies - to look at the past ... whether they actually protect biodiversity. , Dr Bernard ... from human exploitation made common sense, however, up until ...
Breaking Biology News(10 mins):Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3Protected areas proven to protect biodiversity 2
... 2010 (Vienna, Austria) The International AIDS Society (IAS) ... awards, to be presented at plenary sessions during the ... IAS and partners, these awards recognize scientists involved in ... quality of work represented by the 2010 awardees is ...
... how plants grow, reproduce and communicate? Hundreds of international ... Cornell to McGill and the University of Montreal, are ... green: Plant Biology 2010. Media are welcome to attend ... Joint Annual Meetings of American Society of Plant Biologists ...
... It may sound counterintuitive, but LSU Associate Professor of ... the ways organic materials found in the environment, including soils, ... National Science Foundation, or NSF, was so impressed with his ... most prestigious awards the NSF CAREER award. "One of ...
Cached Biology News:International AIDS Society and partners recognize outstanding researchers from around the world at AIDS 2010 2International AIDS Society and partners recognize outstanding researchers from around the world at AIDS 2010 3Flowers do it, trees do it: Symposium on plant reproduction 2LSU researcher looks for new ways to keep a dirty situation clean 2LSU researcher looks for new ways to keep a dirty situation clean 3
...
CQCS kit for etra KR 4i , (other units)....
... The inductive drives of VARIOMAG Magnetic ... as motors, belts, or mechanical bearings, making ... In addition, the VARIOMAG inductive drive can ... water, dust or microorganisms. This is why ...
... Fluoroskan Ascent FL ... fluorometric and luminometric measurement ... long list of advanced ... and Luminoskan Ascent. Fluoroskan ...
Biology Products: